ZTS stock verdict - Value
ZTS
Zoetis Inc.
VALUEHealthcare
$71.05
Strong Buy
$71.05
Heavy$86.71Buy$105.30Fair$123.88Exit$136.26
VALUE85
GROWTH42
QUALITY75
TECHNICAL—
TRUST SCORE
96High
confidence in this read — data completeness, earnings quality & coverage
Technicals: insufficient price history
PROS
- Trades 43% below the model's fair value ($123.88)
- Attractive trailing P/E of 11.2× (earnings yield 8.9%)
- Strong return on equity of 83.1% (TTM)
- Balance sheet holds net cash (cash exceeds total debt)
- Converts 25% of revenue into free cash flow
CONS
- High leverage — debt-to-equity of 2.87
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 110% of net income — profit is backed by real cash
Analysis as of 2026-09-25 · price live, fundamentals from latest filings
Congress Trading — last 90 days
See what senators are buying and selling on ZTS. Sign in to unlock.
📊 Options Flow — Put/Call Ratio
FAQ
Why is ZTS rated Value?
ZTS (Zoetis Inc.) is rated Value because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Strong Buy. Trades 43% below the model's fair value ($123.88) and Attractive trailing P/E of 11.2× (earnings yield 8.9%)
Is ZTS overvalued right now?
ZTS is trading at $71.05 versus an estimated fair value of $123.88. That puts the stock in value territory on this framework. High leverage — debt-to-equity of 2.87
What should I watch before acting on ZTS?
Watch the trust score of 96, the earnings-quality checks, and any red flags. High leverage — debt-to-equity of 2.87